Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of ... - Marketwired (press release)

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of Marketwired (press release)(TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem cell-related therapeutics, today announced that it has entered into an option agreement to exclusively license worldwide rights to a panel of fully and more read more

http://blog.zandcell.com/stem-cell-therapeutics-strengthens-cd47-franchise-with-acquistion-of-marketwired-press-release/?utm_source=rss&utm_medium=rss&utm_campaign=stem-cell-therapeutics-strengthens-cd47-franchise-with-acquistion-of-marketwired-press-release